Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-02-14
2006-02-14
Horlick, Kenneth R. (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007200, C435S007230, C435S069100
Reexamination Certificate
active
06998234
ABSTRACT:
The invention provides methods for prognosis, diagnosis, staging and disease progression in human cancer patients related to expression levels of a plurality of genes that are differentially expressed in anti-angiogenic agent-sensitive and anti-angiogenic agent-resistant vascular endothelial cells as compared to baseline vascular endothelial cells.
REFERENCES:
patent: 4996145 (1991-02-01), Weisenthal
patent: 5464753 (1995-11-01), Chaudhary et al.
patent: 5736129 (1998-04-01), Medenica et al.
patent: 5776747 (1998-07-01), Aebischer et al.
patent: 5994088 (1999-11-01), Mechetner et al.
patent: 6004755 (1999-12-01), Wang
patent: 6036955 (2000-03-01), Thorpe et al.
patent: 6040138 (2000-03-01), Lockhart et al.
patent: 6165709 (2000-12-01), Friend et al.
patent: 6333155 (2001-12-01), Lockhart et al.
patent: 6376169 (2002-04-01), Adams et al.
patent: WO 99/50401 (1999-10-01), None
Borgiani et al., “Comparative DNA analysis of breast cancer by flow cytomertry and image analysis,” Pathologica (Genoa), 86(4):356-359, 1994.
Chen and Huang, “Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells,” British Journal of Pharmacology, 124(6):1029-1040, 1998.
Cordon-Cardo, “Immunohistochemical Analysis of P-Glycoprotein Expression in Normal and Tumor Tissues in Humans,” Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, pp. 303-318, 1991.
Gottesman et al., “Expression of the MDR1 Gene in Normal Human Tissues,” Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, Plenum Press, NY, pp. 279-289, 1991.
Lebow et al., “Analysis of Lymphocyte-Target Conjugates by Flow Cytometry I. Discrimination Between Killer and Non-Killer Lymphocytes Bound to Targets and Sorting of Conjugates Containing One or Multiple Lymphocytes,” Natural Immunity and Cell Growth Regulation, 5(5):221-237, 1986.
Mechetner et al., “Levels of Multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubin,” Clin. Cancer Res., 4:389-98, 1998.
Orfao et al., “A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique,” Cytometry, 17(4):332-339, 1994.
Pepper et al., “BCL-2/BAX Ratios in chronic lymphocytic Leukaemia and their correlation with in vitro apoptosis and clinical resistance,” British Journal of Cancer, 76(7):935-938, 1997.
Seidl et al., “Evaluation of membrane physiology following flurscence activated or magnetic cell separation,” Cytometry, 36(2):102-111, 1999.
Arends et al., “Apoptosis. The role of the endonuclease,” Am. J. Pathol. 136(3):593-608, 1990.
Auerbach et al., “From Primitive Embryonic Precursor Cells To Organ And Tumor-Specific Vascular Endothelial Cells: A Progress Report,” Proc. Annu. Meet Am. Assoc. Cancer Res. 35:663, 1994.
Bange et al., “Molecular targets for breast cancer therapy and prevention,” Nat. Med. 7(5):548-552, 2001.
Battegay, “Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects,” J. Mol. Med. 73(7):333-346, 1995.
Benelli et al., “In vitro models of angiogenesis: the use of Matrigel,” Int. J. Biol. Markers 14(4):243-246, 1999.
Bertram, “The molecular biology of cancer,” Mol. Aspects Med. 21(6):167-223, 2000.
Bichsel et al., “Cancer proteomics: from biomarker discovery to signal pathway profiling,” Cancer J. 7(1):69-78, 2001.
Bussolino e tal., “Molecular mechanisms of blood vessel formation,” Trends Biochem. Sc. 22(7):251-256, 1997.
Conrad-Lapostolle et al., “Optimization of use of UEA-1 magnetic beads for endothelial cell isolation,” Cell Biol. Toxicol. 12(4-6):189-197, 1996.
Coombes et al., “cDNA Array Analysis of Altered Gene Expression in Human Endothelial Cells in Response to Chlamydia pneumoniae Infection,” Infect. Immunol. 69(3):1420-1427, 2001.
Diez et al., “Isolation of full-size mRNA from cells sorted by flow cytometry,” J. Biochem. Biophys. Methods 40(3):69-80, 1999.
Emmert-Buck et al., “Molecular Profiling of Clinical Tissue Specimens: Feasibility and Applications,” J. Mol. Diagn. 2(2):60-66, 2000.
Feng et al., “Transcriptional Profile of Mechanically Induced Genes in Human Vascular Smooth Muscle Cells,” Circ. Res. 85:1118-1123, 1999.
Folkman et al., “Angiogenesis,” J. Biol. Chem. 267(16):10931-10934, 1992.
Folkman, “Angiogenesis in cancer, vascular, rheumatoid and other disease,” Nat. Med. 1(1):27-31, 1995.
Gargett et al., “Isolation, characterization and long-term culture of human myometrial microvascular endothelial cells,” Hum. Reprod. 15(2):293-301, 2000.
Hewett et al., “Human microvessel endothelial cells: isolation, culture and characterization,” In Vitro Cell Dev. Biol. 29A(11):823-830, 1993.
Brunstein et al., “The biology and treatment of chronic myelogenous leukemia,” Oncology 15:23-31, 2001.
Ingber, “Fibronectin Controls Capillary Endothelial Cell Growth by Modulating Cell Shape,” Proc. Nat'l Acad Sci. USA 87:3579-3583, 1990.
Joki et al., “Assessment of alterations in gene expression in recurrent malignant glioma after radiotherapy using complementary deoxyribonucleic acid microarrays,” Neurosurgery 48(1):195-202, 2001.
Jones et al., “The Current Status of Clinical Trials in Anti-Angiogenesis,” Principles and Practices of Oncology Updates 14(1):1-9, 2000.
Koong et al., “Candidate Genes for the Hypoxic Tumor Phenotype,” Cancer Res. 60:883-887, 2000.
Kumar et al., “CD 105 and angiogenesis,” J. Pathol. 178(4):363-366, 1996.
Laird et al., “SU6668 is a Potent Antiangiogenic and Antitumor Agent That Induces Regression of Established Tumors,” Cancer Res. 60:4152-4160, 2000.
Li et al., “Blood-brain barrier genomics,” J. Cereb. Blood Flow Metab. 21(1):61-68, 2001.
Li et al., “Positive and negative hematopoietic cytokines produced by bone marrow endothelial cells,” Cytokine 12(7):1017-1023, 2000.
Martoglio et al., “Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays,” Mol. Med. 6(9):750-765, 2000.
Matsuno et al., “Induction of Lasting Complete Regression of Preformed Distinct Solid Tumors by Targeting the Tumor Vasculature Using Two New Anti-Endoglin Monoclonal Antibodies,” Clin. Cancer Res. 5:371-382, 1999.
Mechetner et al., “Gene Array Analysis of Endothelial Cells Isolated from Human Tumors: A New Approach to the Development of Antiangiogenesis Therapies,” Proc. Annu. Meet Am. Assoc. Cancer Res. 42:566-567, 2001.
Mendel et al., “Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent,” Anticancer Drug Design 15(1):29-41, 2000.
Norris et al., “Serum enhancement of human endothelial cell attachment to and spreading on collagens I and IV does not require serum fibronectin or vitronectin,” J. Cell Sci. 95(2):255-262, 1990.
Pitas et al., “Uptake of Chemically Modified Low Density Lipoproteins in Vivo is Mediated by Specific Endothelial Cells,” J. Cell. Biol. 100:103-117, 1985.
Raynal et al., “Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins,” Biochem. Et Biophys. Acta. 1197(1):63-93, 1994.
Rosfiord et al., “Application of flow cytometry in the analysis and sterile sorting of cell populations based on integrin expression,” Methods Mol. Biol. 129:79-90, 1999.
Saaristo et al., “Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis,” Oncogen
Fruehauf John P.
Mechetner Eugene
Horlick Kenneth R.
McDonnell Boehnen & Hulbert & Berghoff LLP
Oncotech, Inc.
Tung Joyce
LandOfFree
Methods for cancer prognosis and diagnosis relating to tumor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for cancer prognosis and diagnosis relating to tumor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for cancer prognosis and diagnosis relating to tumor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3709560